TCIIS
IBB icon

TIAA-CREF Individual & Institutional Services’s iShares Biotechnology ETF IBB Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
3,743
+826
+28% +$142K ﹤0.01% 396
2026
Q1 		$493K Buy
+2,917
New +$499K ﹤0.01% 440

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's IBB Position: Q2 2026 in Review

TIAA-CREF Individual & Institutional Services increased its iShares Biotechnology ETF (IBB) stake by 28% in Q2 2026, buying an estimated $142K and bringing the position to 3,743 shares worth $712K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

TIAA-CREF Individual & Institutional Services first reported a position in IBB in Q1 2026 and has held it in 2 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • TIAA-CREF Individual & Institutional Services held 3,743 shares of iShares Biotechnology ETF worth $712K as of Q2 2026.
  • TIAA-CREF Individual & Institutional Services bought 826 iShares Biotechnology ETF shares in Q2 2026, an estimated $142K.
  • iShares Biotechnology ETF made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q2 2026, its #396 holding.
  • TIAA-CREF Individual & Institutional Services first reported a position in iShares Biotechnology ETF in Q1 2026 and has held it in 2 quarters since.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q2 2026, filed 10 Aug 2026.